SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-18-000019
Filing Date
2018-02-14
Accepted
2018-02-14 13:46:11
Documents
37
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED DECEMBER 31, 2017 bivi-20171231.htm 10-Q 213143
2 EXHIBIT 31.1 bivi-20171231_10qex31z1.htm EX-31.1 12111
3 EXHIBIT 32.1 bivi-20171231_10qex32z1.htm EX-32.1 5804
  Complete submission text file 0001520138-18-000019.txt   1276719

Data Files

Seq Description Document Type Size
4 XBRL CALCULATION FILE bivi-20171231_cal.xml EX-101.CAL 23783
5 XBRL DEFINITION FILE bivi-20171231_def.xml EX-101.DEF 30576
6 XBRL LABEL FILE bivi-20171231_lab.xml EX-101.LAB 111631
7 XBRL PRESENTATION FILE bivi-20171231_pre.xml EX-101.PRE 84428
8 XBRL INSTANCE FILE bivi-20171231.xml EX-101.INS 211034
9 XBRL SCHEMA FILE bivi-20171231.xsd EX-101.SCH 16315
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 312-283-5793
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 18610567
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1